
Vivos Therapeutics VVOS
$ 1.47
0.0%
Annual report 2025
added 04-15-2026
Vivos Therapeutics Operating Cycle 2011-2026 | VVOS
Annual Operating Cycle Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 7.67 | 8.71 | 18.9 | 28.5 | 42.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.3 | 7.67 | 21.2 |
Quarterly Operating Cycle Vivos Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3 | 28.1 | 17.4 | - | 10 | 10.3 | 9.7 | - | 7.67 | - | - | - | 17.8 | 19.6 | 29.1 | - | 50.5 | 29.1 | 18.2 K | - | 6.21 K | 6.01 K | 5.03 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 K | 7.67 | 2.23 K |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
BIO
|
304 | $ 295.96 | - | $ 8.35 B | ||
|
Bruker Corporation
BRKR
|
274 | $ 39.48 | - | $ 5.88 K | ||
|
Align Technology
ALGN
|
171 | $ 186.53 | - | $ 14 B | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
205 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 3.52 | - | $ 132 M | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
64 | $ 12.65 | - | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
793 | $ 17.85 | - | $ 419 M | ||
|
Cytosorbents Corporation
CTSO
|
212 | $ 0.59 | - | $ 36.7 M | ||
|
LENSAR
LNSR
|
231 | $ 6.25 | - | $ 74.7 M | ||
|
Boston Scientific Corporation
BSX
|
169 | $ 64.61 | - | $ 95.6 B | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
250 | $ 10.46 | - | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
228 | $ 25.71 | - | $ 217 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
502 | $ 2.74 | - | $ 7.6 M | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Stryker Corporation
SYK
|
408 | $ 341.24 | - | $ 130 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Tactile Systems Technology
TCMD
|
124 | $ 25.35 | - | $ 580 M | ||
|
TELA Bio
TELA
|
216 | $ 0.66 | 8.79 % | $ 31 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
TransMedics Group
TMDX
|
127 | $ 116.11 | - | $ 3.95 B | ||
|
Tandem Diabetes Care
TNDM
|
284 | $ 20.66 | - | $ 1.41 B | ||
|
Globus Medical
GMED
|
347 | $ 94.55 | - | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
381 | $ 1.94 | - | $ 1.18 M | ||
|
Butterfly Network
BFLY
|
866 | $ 4.86 | - | $ 1.03 B | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Inogen
INGN
|
83.5 | $ 6.2 | - | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
177 | $ 1.04 | - | $ 17.6 M | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
314 | $ 10.99 | - | $ 394 M | ||
|
Inspire Medical Systems
INSP
|
351 | $ 56.64 | - | $ 1.66 B | ||
|
Varex Imaging Corporation
VREX
|
254 | $ 11.78 | - | $ 488 M |